drugset / Trial / NCT00408876

Duloxetine Versus Placebo in Chronic Low Back Pain

NCT00408876

Phase 3 Completed 404 enrolled Eli Lilly and Company
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The primary purpose of your participation in this study is to help answer the following research question, and not to provide you treatment for your condition--Whether duloxetine once daily can help patients with Chronic Low Back Pain.

Timeline

Start
2006-12
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 20 mg Oral
Subject Duloxetine Small molecule 60 mg Oral
Subject Duloxetine Small molecule 120 mg Oral

Indications

No indication recorded.